Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Excellus BlueCross BlueShieldCommercial · Coverage · Durable Medical Equipment & Supplies · NY · NeurologyMedium impact

Specialized Neuromodulation for Specific Conditions 1.01.62

Effective date
May 21, 2026
Identified
Jun 20, 2026

Summary

Excellus policy 1.01.62 (current effective date May 21, 2026) is a new policy, derived from policy 1.01.55, that states Transcutaneous Afferent Patterned Stimulation (TAPS) devices such as Cala One, Cala Trio and Felix NeuroAI, and Remote Electrical Neuromodulation (REN) devices such as Nerivio, are investigational for all indications. The Nerivio device is a wireless stimulator applied to the lateral upper arm in 45-minute sessions for acute migraine, and the Cala Trio is a hand-specific device worn like a wristwatch to relieve tremors in adults with essential tremor.

Get alerts when payers change rules like this one

We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.

Get Excellus BlueCross BlueShield alertsPolicy Monitoring is free. No card required.

What to do

Action · 2 steps
01Already effective 05/21/26: Billing team should treat TAPS devices (Cala One, Cala Trio, Felix NeuroAI) and REN devices (Nerivio) as investigational for all indications under this policy.
02Check the codes against that status before billing: E0734 and A4542 are marked (E/I), E1399 is marked (*E/I when used for the modalities in this policy), and A4540 is listed for Nerivio.

Codes mentioned

A4540A4542E0734E1399G25.0

Original notice

Specialized Neuromodulation for Specific Conditions 1.01.62
excellusbcbs.com · Always check the source before changing claims.
View original ↗

Related changes

See all Excellus BlueCross BlueShield changes →
Continuous Passive Motion Device (CPM) in the Home Setting 1.01.02MediumEffective Oct 22, 2026 · Durable Medical Equipment & SuppliesStereotactic Radiosurgery and Stereotactic Body Radiation Therapy 6.01.12MediumEffective Nov 16, 2025 · Radiation TreatmentCryotherapy (Cold Therapy) Devices 1.01.21MediumEffective Jun 18, 2026 · Bone & Joints (Orthopedic)Specialty Enclosure Bed Systems 1.01.56MediumEffective May 15, 2026 · Durable Medical Equipment & SuppliesBrowse every Excellus BlueCross BlueShield change in the policy list

Related policy hubs

Excellus BlueCross BlueShield policiesNY policy changesNeurologyCode A4540Code A4542Code E0734Code E1399Code G25.0

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account